Advances in Immunotherapy for Glioblastoma Multiforme
Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults. Patients with GBM have poor outcomes, even with the current gold-standard first-line treatment: maximal safe resection combined with radiotherapy and temozolomide chemotherapy. Accumulating evidence suggests th...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wiley
2017-01-01
|
| Colección: | Journal of Immunology Research |
| Acceso en línea: | http://dx.doi.org/10.1155/2017/3597613 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|